Alert/Advisory
Alerts provide important advice about health products that may include safety information.
Latest alerts
-
Extra safety information is being added to all montelukast products to highlight the existing warnings about serious behaviour and mood-related changes.
-
Boston Scientific have advised that subsets of ACCOLADE and VISIONIST pacemakers have an increased risk of permanently entering Safety Mode which has limited functionality.
-
Pharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.
Latest articles
-
More prominent safety warnings about the neuropsychiatric effects of montelukast
Additional safety information is being added to all montelukast products to strengthen and highlight existing warnings about serious neuropsychiatric events. -
Recall reforms update and new procedure
Recall reforms program update and preview of the PRAC Version 1.0. -
Elemental impurities in traditional Chinese medicines (TCMs)
TCMs sold in Australia are carefully regulated to ensure safety and quality.
Latest publications
-
In consultation with the TGA, Edgewell has taken a precautionary approach and commenced a recall of all batches of these three products from the Australian market.
-
TGA Laboratories has released a report detailing testing of alkyl nitrite products